Patents Represented by Attorney Novartis Vaccines & Diagnostics SRL
  • Patent number: 7485304
    Abstract: A non-toxic mucosal adjuvant is provided which may be admixed with further antigens to provide a vaccine administrable to mucosal surfaces in organisms including man. Preferably, the non-toxic mucosal adjuvant is a detoxified mutant of a bacterial ADP-ribosylating toxin, optionally comprising one or more amino acid additions, deletions or substitutions.
    Type: Grant
    Filed: April 6, 2006
    Date of Patent: February 3, 2009
    Assignee: Novartis Vaccines and Diagnostics SRL
    Inventor: Rino Rappuoli